ACMAugust 17, 2026 at 2:11 PM UTCCommercial & Professional Services

AECOM Shares Under Pressure After Massive Earnings Miss and Guidance Cut, Triggering Investor Investigation

Read source article

What happened

AECOM reported quarterly revenue down 14.2% year-over-year to $3.59 billion and an adjusted loss per share of $0.50, far below the consensus estimate of $1.46–$1.51, with full-year adjusted EPS guidance reset to roughly $4.05 at the midpoint. The miss prompted law firm Levi & Korsinsky to announce an investigation into potential securities law violations, adding legal overhang to the stock. This sharp deterioration contradicts the previously issued FY2026 guidance for adjusted EPS of $5.65–$5.85 and suggests deeper operational or execution problems than disclosed in the latest 10-K. The stock had already been trading about 40% above the FCF-based DCF anchor of $70 per share, leaving no margin of safety for such a negative surprise. The master report’s WAIT rating now appears too benign given the magnitude of the miss and the reset of earnings expectations.

Implication

The abrupt guidance cut to $4.05 from $5.65–$5.85 reflects a fundamental break in the earnings trajectory, not just a one-time adjustment, and calls into question management’s forecasting ability. The securities investigation adds legal and reputational risk that could further pressure the share price. Given the stock still trades above the DCF-based intrinsic value of $70, the risk/reward is unfavorable for new capital. Existing holders should reassess the thesis and consider whether the legacy liabilities and project risks highlighted in the 10-K are materializing more rapidly than expected. A sustained recovery would require clear evidence that the revenue decline and margin erosion are temporary and that backlog conversion is unaffected, which is unlikely in the near term.

Thesis delta

The master report’s WAIT rating was based on a rich valuation offset by strong operational trends; the reported earnings miss and guidance cut invalidate the premise of continued EPS growth. The thesis shifts to SELL or AVOID as the new information suggests either a structural decline in demand or execution failures that were not anticipated. The legal investigation adds further downside risk.

Confidence

high